Connect with us

Hi, what are you looking for?


Jim Cramer on Chipotle stock: ‘I like it to go to $2,000’

Shares of Chipotle Mexican Grill Inc (NYSE: CMG) are already up more than 25% for the year but famed investor Jim Cramer is convinced that they’re not out of room to run just yet.

Cramer’s bull case for the Chipotle stock

Cramer expects this chain of fast casual restaurants to see continued growth in sales on the back of an amazing variety on its menu. On CNBC’s “Squawk on the Street”, he said:

They’re back to having menu items that drive their sales up and it’s an exciting time because the stock is finally breaking out after multi-year consolidation and I like it to go to $2,000.

The Mad Money host is constructive also because he has confidence in the leadership of Brian Niccol who has been at the helm since early 2018.

At writing, the price-to-earnings multiple on Chipotle stock is well below its average over the past five years.

Truist analyst is also bullish on Chipotle stock

Cramer’s bullish view on the food stock is in line with Truist Securities’ analyst Jake Bartlett.

On Monday, Bartlett reiterated his “buy” rating on Chipotle stock and raised his price target to $1,960 a share that suggests about a 13% upside on its previous close.

He expects improvements in the avocado market to be a meaningful tailwind for Chipotle Mexican Grill Inc. A 10% change in “butter fruit” prices, he estimates, could mean a 30 basis points effect on the company’s margins and 69 cents a share effect on is earnings.

Chipotle is expected to earn $8.84 a share in its current financial quarter versus $5.7 per share a year ago.

The post Jim Cramer on Chipotle stock: ‘I like it to go to $2,000’ appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.